SHPK and glioblastoma: Similarly, ERS compromised the cytotoxicity of SHK against glioblastoma stem cells (GSC), and inhibiting ERS with 4-phenylbutyric acid markedly enhanced the cytotoxicity of SHK in GSC (Liu et al., 2015).